2015MEDIA KIT

BioNews Services, LLC, 5307 E. Mockingbird Lane, Fifth Floor, Dallas, TX 75206(972) 971-2793, cbc@bionewsservices.com

No other science or research-related publication on the web is producing news on a daily basis for multiple sclerosis patients, caregivers and HCPs. Multiple Sclerosis News Today (MSNT) is filling an unmet need in healthcare news journalism by providing patients and their families with a reliable MS focused news journal they can engage with on a daily basis for the latest news and MS resources.

Our high level of commitment to the MS patient population and the consistency in which we publish news leads to a level of trust and authority that filters down to our clients. Advertising on MSNT provides companies a non-branded approach to generating awareness and promoting their brand, product or service to a user base that is both targeted and open to messaging that pertains to their disease focus.

On average, we publish 40 – 50 new MS related original content articles each month, keeping the patient and caregiver population informed and empowered with news and information delivered in near real-time.

We enjoy industry leading engagement, trust and credibility with our readers. MSNT’s writing team boasts a diverse array of talented, experienced professionals. Our team includes PhDs, journalists,

biotech business professionals, and online marketing experts, all of whom come together to create one of the leanest, most flexible digital content-based marketing platforms on the web today.

This content model, together with our aggressive demographic targeting via social media and search engine optimization ensures that ads on MSNT perform far above industry benchmarks for click-through rates (CTR) and conversions. The only users interacting with MSNT content are people interested in multiple sclerosis, as a result, there are no wasted impressions or empty ad visibility – guaranteeing that client’s products or brands are in front of a highly targeted audience.

BioNews Services, LLC, 5307 E. Mockingbird Lane, Fifth Floor, Dallas, TX 75206(972) 971-2793, cbc@bionewsservices.com

Reader Survey

Reader Profile

a. Visit most often

0 5 10 15 20 25 30 35

Other (please specify)

Medical Xpress

MedPage Today

Medical News Today

Everyday Health

WebMD

National MS Society

Multiple Sclerosis News Today

32.52%8.74%

0.49%0.49%0.49%0.00%

22.82%

c. Trust

b. Frequency

34.47%

a. Age

0 5 10 15 20 25 30 35 40

60 or older

50-59

40-49

30-39

21-29

18-20

17 or younger 0.06%

0.23%

2.64%

11.55%

23.74%

37.16%

24.62%

b. Gender

0

10

20

30

5 or more 3-52-31

28.21% 29.91%

14.96%

26.92%

25.75%

39.91%

26.18%

6.87%

1.29%

0 5 10 15 20 25 30 35 40

NOT AT ALL

A LITTLE

A MODERATEAMOUNT

A LOT

A GREATDEAL

d. Easy to understand

0

10

20

30

40

50

NOT ATALL EASY

NOT SOEASY

MODERATELYEASY

VERYEASY

EXTREMELYEASY

16.09%

48.70%

31.30%

3.04%0.87%

e. Needs

0

10

20

30

40

50

NOT ATALL WELL

NOT SOWELL

MODERATELYWELL

VERYWELL

EXTREMELYWELL

13.68%

41.88%

35.04%

6.41%

2.99%

Female

71.63%

Male

28.37%

c. MS Type

0 10 20 30 40 50

DON’T KNOW/UNSURE

SECONDARY PROGRESSIVEMULTIPLE SCLEROSIS (SPMS)

RELAPSING REMITTINGMULTIPLE SCLEROSIS (RRMS)

PRIMARY RELAPSINGMULTIPLE SCLEROSIS (PRMS)

PRIMARY PROGRESSIVEMULTIPLE SCLEROSIS (PPMS) 12.72%

3.22%

46.42%

26.08%

11.55%

d. Therapy

OTHER (PLEASE SPECIFY)MEDICAL CANNABIS

CORTICOSTEROID (SOLUMEDROL)MUSCLE RELAXANTS (LIORESAL, ZANAFLEX)

LOW DOSE NALTREXONVITAMIN D

PLASMA EXCHANGELEMTRADA (ALEMTUZUMAB)

AUBAGIO (TERIFLUNOMIDE)EXTAVIA (INTERFERON BETA 1B)

BETASERON (INTERFERON BETA 1B)TYSABRI (NATALIZUMAB)

GILENYA (FINGOLIMOD)COPAXONE (GLATIRAMER ACITATE)

REBIF (INTERFERON BETA 1A)AVONEX (INTERFERON BETA 1A)

TECFIDERA (DIMETHYL FUMARATE)

visits per week

BioNews Services, LLC, 5307 E. Mockingbird Lane, Fifth Floor, Dallas, TX 75206(972) 971-2793, cbc@bionewsservices.com

Social Media

a. Facebook

b. Other social media accounts

Twitter, Pinterest, Google+, LinkedIn

Likes – 6,300+

Engagement / Like

0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35

MS Society

World MS Day

MyMSTeam

National MS Society

MSNT 0.32

0.03

0.035

0.03

0.18

i.

Email list

Number8,000+

Growth200/week (avg.)

Open33.10%

Click Rate11.30%

Analytics

Time on page2m 55s

Device

Desktop

Mobile

40.61%

59.39%

Acquisition

ReferralDirectSocial

Organic 38%

34%

21%

7%

New Fans – 200

Engagement – 15,003

Reach – 570,808 Clicks – 15,466

Share – 2,855

Comments – 551

Facebook Overview (30 Days)